Anti-TNFRSF10B/TRAILR2/CD262 Antibody (Drozitumab)
Catalog No.
F1056
Anti-TNFRSF10B/TRAILR2/CD262 Antibody (Drozitumab)
Featured Products
Drozitumab (PRO 95780) is a human agonist monoclonal antibody that binds to the death receptor DR5. Drozitumab has potent antitumor activity against rhabdomyosarcoma.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
143.06 kDa
Dry ice
912628-39-8
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
RG-7425, RG7425
100 mM Pro 20 mM Arg pH 5.0. No preservative!
O14763
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized Cynomolgus TRAIL R2/DR5/ TNFRSF10B Protein, His Tag at 2 ug/mL can bind drozitumab
TNFRSF10B / TRAILR2 / CD262
Please avoid freeze-thaw cycles.